Cargando…

A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies

Detalles Bibliográficos
Autor principal: Tikhonova, Maria A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940682/
https://www.ncbi.nlm.nih.gov/pubmed/31901571
http://dx.doi.org/10.1016/j.ebiom.2019.11.036
_version_ 1783484384708395008
author Tikhonova, Maria A.
author_facet Tikhonova, Maria A.
author_sort Tikhonova, Maria A.
collection PubMed
description
format Online
Article
Text
id pubmed-6940682
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69406822020-01-06 A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies Tikhonova, Maria A. EBioMedicine Commentary Elsevier 2019-12-31 /pmc/articles/PMC6940682/ /pubmed/31901571 http://dx.doi.org/10.1016/j.ebiom.2019.11.036 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Tikhonova, Maria A.
A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies
title A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies
title_full A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies
title_fullStr A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies
title_full_unstemmed A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies
title_short A new avenue for treating Parkinson's disease targeted at aggrephagy modulation and neuroinflammation: Insights from in vitro and animal studies
title_sort new avenue for treating parkinson's disease targeted at aggrephagy modulation and neuroinflammation: insights from in vitro and animal studies
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940682/
https://www.ncbi.nlm.nih.gov/pubmed/31901571
http://dx.doi.org/10.1016/j.ebiom.2019.11.036
work_keys_str_mv AT tikhonovamariaa anewavenuefortreatingparkinsonsdiseasetargetedataggrephagymodulationandneuroinflammationinsightsfrominvitroandanimalstudies
AT tikhonovamariaa newavenuefortreatingparkinsonsdiseasetargetedataggrephagymodulationandneuroinflammationinsightsfrominvitroandanimalstudies